Cytoagents Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cytoagents

Access the complete profile.

Cytoagents Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	100 S Commons Ste 102 Pittsburgh, PA 15212

Note: Revenues for privately held companies are statistical evaluations.


Cytoagents's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cytoagents's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Cytoagents is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Cytoagents Annual Revenue and Growth Rate

Cytoagents	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cytoagents's revenues are gauged from an analysis of company filings.

Cytoagents's Income Statement (based on Industry Averages)

Cytoagents P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Cytoagents has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 16, 2023	23	46%	$15 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Cytoagents is developing and marketing. Cytoagents doesn't have any recent trademark applications, indicating Cytoagents is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CYTOONC Scientific research and development services in the field of biotechnology	10/04/2021
CYTOAGENTS Scientific research and development services in the field of biotechnology	10/04/2021
CYTOSHIELD Scientific research and development services in the field of biotechnology	10/04/2021

See all trademarks and details in the Full Report.

Market Share of Cytoagents's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cytoagents, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Cytoagents. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PPG INDUSTRIES	Pittsburgh, PA	100
LANXESS	Pittsburgh, PA	18
COVESTRO	Pittsburgh, PA	15
NEVILLE CHEMICAL	Pittsburgh, PA	1
ALPHA AROMATICS	Pittsburgh, PA	0
KROFF	Pittsburgh, PA	0
UNIPACK	Pittsburgh, PA	0
PRESSURE CHEMICAL	Pittsburgh, PA	0
KROFF CHEMICAL	Pittsburgh, PA	0
INTERPHASE MATERIALS	Pittsburgh, PA	0

Future Competition: Cytoagents's Fastest Growing Competitors

These companies are in the same general field as Cytoagents and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)